Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,652,509
+$317,282 QoQ
Shares Held
171,998
-20.9% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
2.97%
of 13F equity value
Holder Rank
#102
of 477 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. CYTK ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
562,630 | $105,369,346 | |
| 2 | NKTR |
Nektar Therapeutics
|
318,380 | $22,226,107 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
739,014 | $19,007,440 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
497,240 | $18,532,134 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $15,136,597 | |
| 6 | CYTK |
Cytokinetics Inc
This page
|
171,998 | $14,652,509 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
441,829 | $13,621,588 | |
| 8 | ASND |
Ascendis Pharma A/S
|
48,469 | $12,927,651 |
All Filings in CYTK
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,652,509 | 171,998 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,335,227 | 217,497 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,573,149 | 370,997 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,705,902 | 394,940 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,153,224 | 398,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,999,639 | 398,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,726,624 | 398,100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,019,680 | 398,100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,569,058 | 398,100 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $27,910,791 | 398,100 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,396,000 | 400,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,127,189 | 479,538 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,853,783 | 332,734 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,729,859 | 276,495 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,430,650 | 183,995 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,914,557 | 183,995 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,309,638 | 211,495 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,785,130 | 211,495 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,112,004 | 134,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,254,500 | 175,000 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||